|
|
||||||||
Ann Thorac Surg 1999;67:1981-1982
© 1999 The Society of Thoracic Surgeons
a Department of Thoracic and Cardiovascular Surgery, Lahey Hitchcock Clinic, Burlington, Massachusetts, USA
Address reprint requests to Dr Svensson, Department of Thoracic and Cardiovascular Surgery, Lahey Hitchcock Clinic, 41 Mall Rd, Burlington, MA 01805
Presented at the Aortic Surgery Symposium VI, April 30May 1, 1998, New York, NY.
Background. The establishment of hemostasis without the excessive transfusion of homologous blood and blood products is critical to successful aortic surgery.
Methods and Results. By using preoperative autologous blood donation and intraoperative blood conservation measures, 85% of patients can undergo aortic surgical procedures without homologous blood or product transfusions, and almost three-quarters of patients will still not have required homologous transfusions by the time of discharge. In contrast, three-quarters of those patients who cannot donate blood preoperatively will require homologous blood transfusions.
Conclusions. The strategy described is safe: our overall survival rate for 204 patients has been 98%, with a 1% incidence of stroke.
This article has been cited by other articles:
![]() |
V. Casati, L. Sandrelli, G. Speziali, G. Calori, M. A. Grasso, and S. Spagnolo Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: A prospective, randomized, double-blind, placebo-controlled study J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1084 - 1091. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |